Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1969 5
1970 6
1971 7
1972 3
1973 2
1974 7
1975 9
1976 6
1977 7
1978 8
1979 10
1980 19
1981 15
1982 12
1983 13
1984 31
1985 26
1986 27
1987 36
1988 26
1989 26
1990 21
1991 19
1992 22
1993 35
1994 40
1995 33
1996 46
1997 32
1998 34
1999 22
2000 32
2001 24
2002 28
2003 26
2004 12
2005 15
2006 16
2007 27
2008 24
2009 15
2010 16
2011 14
2012 13
2013 15
2014 4
2015 4
2016 1
2017 8
2018 7
2019 2
2020 5
2021 8
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

897 results
Results by year
Filters applied: . Clear all
Page 1
A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias.
Cortes JE, Kim DW, Pinilla-Ibarz J, le Coutre P, Paquette R, Chuah C, Nicolini FE, Apperley JF, Khoury HJ, Talpaz M, DiPersio J, DeAngelo DJ, Abruzzese E, Rea D, Baccarani M, Müller MC, Gambacorti-Passerini C, Wong S, Lustgarten S, Rivera VM, Clackson T, Turner CD, Haluska FG, Guilhot F, Deininger MW, Hochhaus A, Hughes T, Goldman JM, Shah NP, Kantarjian H; PACE Investigators. Cortes JE, et al. Among authors: goldman jm. N Engl J Med. 2013 Nov 7;369(19):1783-96. doi: 10.1056/NEJMoa1306494. Epub 2013 Nov 1. N Engl J Med. 2013. PMID: 24180494 Free PMC article. Clinical Trial.
Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results.
Hughes T, Deininger M, Hochhaus A, Branford S, Radich J, Kaeda J, Baccarani M, Cortes J, Cross NC, Druker BJ, Gabert J, Grimwade D, Hehlmann R, Kamel-Reid S, Lipton JH, Longtine J, Martinelli G, Saglio G, Soverini S, Stock W, Goldman JM. Hughes T, et al. Among authors: goldman jm. Blood. 2006 Jul 1;108(1):28-37. doi: 10.1182/blood-2006-01-0092. Epub 2006 Mar 7. Blood. 2006. PMID: 16522812 Free PMC article. Review.
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.
O'Brien SG, Guilhot F, Larson RA, Gathmann I, Baccarani M, Cervantes F, Cornelissen JJ, Fischer T, Hochhaus A, Hughes T, Lechner K, Nielsen JL, Rousselot P, Reiffers J, Saglio G, Shepherd J, Simonsson B, Gratwohl A, Goldman JM, Kantarjian H, Taylor K, Verhoef G, Bolton AE, Capdeville R, Druker BJ; IRIS Investigators. O'Brien SG, et al. Among authors: goldman jm. N Engl J Med. 2003 Mar 13;348(11):994-1004. doi: 10.1056/NEJMoa022457. N Engl J Med. 2003. PMID: 12637609 Free article. Clinical Trial.
Treatment strategies for CML.
Goldman JM. Goldman JM. Best Pract Res Clin Haematol. 2009 Sep;22(3):303-13. doi: 10.1016/j.beha.2009.08.001. Best Pract Res Clin Haematol. 2009. PMID: 19959082 Review.
Chronic myeloid leukemia--some topical issues.
Mughal T, Cortes J, Cross NC, Donato N, Hantschel O, Jabbour E, Kantarjian H, Melo JV, Skorski T, Silver RT, Goldman JM. Mughal T, et al. Among authors: goldman jm. Leukemia. 2007 Jul;21(7):1347-52. doi: 10.1038/sj.leu.2404733. Epub 2007 May 10. Leukemia. 2007. PMID: 17495971 Review. No abstract available.
Chronic myeloid leukemia.
Deininger MW, Goldman JM. Deininger MW, et al. Among authors: goldman jm. Curr Opin Hematol. 1998 Jul;5(4):302-8. doi: 10.1097/00062752-199807000-00010. Curr Opin Hematol. 1998. PMID: 9747637 Review.
In Response.
Goldman JM. Goldman JM. Anesth Analg. 2017 Aug;125(2):707-708. doi: 10.1213/ANE.0000000000002246. Anesth Analg. 2017. PMID: 28654431 No abstract available.
Chronic myelogenous leukemia.
Druker BJ, Sawyers CL, Capdeville R, Ford JM, Baccarani M, Goldman JM. Druker BJ, et al. Among authors: goldman jm. Hematology Am Soc Hematol Educ Program. 2001:87-112. doi: 10.1182/asheducation-2001.1.87. Hematology Am Soc Hematol Educ Program. 2001. PMID: 11722980 Review.
Current pre-clinical and clinical advances in the BCR-ABL1-positive and -negative chronic myeloproliferative neoplasms.
Mughal TI, Vannucchi AM, Soverini S, Bazeos A, Tibes R, Saglio G, Abdel-Wahab O, Pardanani A, Hehlmann R, Barbui T, Van Etten R, Tefferi A, Goldman JM. Mughal TI, et al. Among authors: goldman jm. Haematologica. 2014 May;99(5):797-801. doi: 10.3324/haematol.2013.097832. Haematologica. 2014. PMID: 24790057 Free PMC article. Review. No abstract available.
The heterogeneity and diversity of hypertension in CKD.
Goldman JM, Cohen DL, Sim JJ. Goldman JM, et al. Adv Chronic Kidney Dis. 2015 Mar;22(2):86-7. doi: 10.1053/j.ackd.2014.12.003. Adv Chronic Kidney Dis. 2015. PMID: 25704343 No abstract available.
897 results